Search results

Back
1 - 10 of 56 Search results
   14 December 2023  - 4 mins read

14 December 2023  - 4 mins read

Music and Medicine: Understanding the role of epigenetics in cancer research

Dr. Amauri Soares, VP Head of Early Development & Innovation Oncology at Ipsen usesmusic to explain the importance of understanding the genetics of cancer and how the emerging field ofepigenetics could unlock a new paradigm for precision medicine....

   14 May 2023

14 May 2023

ONCOLOGY_PICTO_72x72pix

...

    -  09 November 2022

 -  09 November 2022

Onivyde® regimen demonstrated statistically significant improvement in overall survival in previously untreated metastatic pancreatic ductal adenocarcinoma

PARIS, FRANCE, 9 November 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) announced the Phase III NAPOLI 3 trial of Onivyde® (irinotecan liposome injection) plus 5 fluorouracil/leucovorin and oxaliplatin (NALIRIFOX regimen) met its primary endpoint d...

    -  28 April 2023

 -  28 April 2023

Our Culture

...

    -  13 April 2023

 -  13 April 2023

Our History

...

    -  13 April 2023

 -  13 April 2023

Partnering

...

    -  13 April 2023

 -  13 April 2023

Patients

...

    -  13 April 2023

 -  13 April 2023

Pipeline

As a global biopharmaceutical company with a focus on innovation and specialty care, Ipsen is building a strong and sustainable portfolio of medicines to meet patients’ and their healthcare teams’ needs. We prioritize best-in-class and first-in-class t...

    -  18 April 2023

 -  18 April 2023

Research & Development

...

    -  13 April 2023

 -  13 April 2023

Responsibility

...

1 … 3 4 5 6